WESPAC Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,428
Closed -$926K 189
2025
Q3
$926K Sell
3,428
-25
-0.7% -$6.8K 0.54% 63
2025
Q2
$952K Sell
3,453
-397
-10% -$108K 0.67% 56
2025
Q1
$1.02M Buy
+3,850
New +$950K 0.83% 36
2018
Q4
Sell
-2,986
Closed -$508K 110
2018
Q3
$508K Buy
2,986
+964
+48% +$162K 0.3% 94
2018
Q2
$331K Sell
2,022
-939
-32% -$153K 0.34% 83
2018
Q1
$479K Buy
2,961
+1,172
+66% +$187K 0.29% 97
2017
Q4
$261K Sell
1,789
-1,600
-47% -$228K 0.24% 102
2017
Q3
$460K Buy
3,389
+7
+0.2% +$884 0.3% 96
2017
Q2
$424K Buy
3,382
+964
+40% +$115K 0.29% 99
2017
Q1
$287K Sell
2,418
-276
-10% -$33.2K 0.33% 91
2016
Q4
$311K Buy
+2,694
New +$300K 0.35% 82
2016
Q1
Sell
-16,811
Closed -$1.52M 95
2015
Q4
$1.52M Buy
16,811
+3,441
+26% +$324K 1.76% 21
2015
Q3
$1.24M Sell
13,370
-6,648
-33% -$632K 2.18% 20
2015
Q2
$1.86M Buy
+20,018
New +$1.87M 1.4% 28

Other funds holding CME

WESPAC Advisors's CME Position: Q4 2025 in Review

WESPAC Advisors sold out of CME Group (CME) in Q4 2025, closing a stake of 3,428 shares — an estimated $926K sold.

WESPAC Advisors first reported a position in CME in Q2 2015 and held it in 14 quarters. The position peaked at $1.86M in Q2 2015. 1,736 funds tracked by Wall St. Rank hold CME as of Q4 2025.

  • WESPAC Advisors reported no remaining CME Group position as of Q4 2025 after selling out during the quarter.
  • WESPAC Advisors sold 3,428 CME Group shares in Q4 2025, an estimated $926K.
  • WESPAC Advisors first reported a position in CME Group in Q2 2015 and held it in 14 quarters.
  • WESPAC Advisors's CME Group position peaked at $1.86M in Q2 2015.
  • 1,736 funds tracked by Wall St. Rank held CME Group as of Q4 2025.

Based on WESPAC Advisors's 13F filing for Q4 2025, filed 14 Jan 2026.